Patient, tumor and metastasis characteristics are shown in Table 1
Patient, tumor and metastasis characteristics are shown in Table 1. focusing on these receptors with radionuclides might be applied for most individuals. Conclusions At least one of the EGFR- or HER2-receptors was present in AZD-7648 most instances and co-expressed in more than half the cases. It is therefore interesting to deliver radionuclides for whole-body receptor-analysis, dosimetry and therapy. This can hopefully compensate for resistance to additional therapies and more patients can hopefully become treated with curative instead of palliative intention. strong class="kwd-title" Keywords: EGFR, HER2, radionuclides, resistance, urinary bladder malignancy metastases Intro Biological resistance to both EGFR- and HER2-targeted therapies, due to mutations in for example PI3K/AKT, Ras/Raf/Mek/Erk or additional intracellular transmission pathways has been observed for many types of malignancy.1C4 Urinary bladder malignancy is at present not generally considered…